Similar to CCT3, overexpression of CCT6A has been found in many malignancies, including liver cancers (15) as well as breast cancer (31) and lung cancer (32), and is associated with clinical prognosis and TNM stage. This evidence concerns the gene CCT3 and liver cancer.